Revenue, last quarter
$4.3M
+10.4% vs same quarter last year
Net income
−$959.5K
−42.8% vs same quarter last year
EPS, diluted
−$0.05
−58.6% vs same quarter last year
Operating cash flow
$507.2K
+235.8% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY26 | $16M | −$2.4M |
| FY25 | $13.8M | −$8.4M |
| FY24 | $12.1M | −$14.1M |
| FY23 | $9.6M | −$18.7M |
| FY22 | $7.7M | −$29.1M |
| FY21 | $3.4M | −$15.5M |
| FY20 | $1.4M | −$11.1M |
| FY19 | $398.2K | −$8.6M |
| FY18 | - | −$8.6M |
| FY17 | - | −$7.8M |
| FY16 | - | −$5.2M |
| FY15 | - | −$1.7M |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY26 | 80.9% | 10.6% | −15% |
| FY25 | 76.6% | −17.8% | −61.1% |
| FY24 | 69.3% | −73.2% | −116.8% |
| FY23 | 56.5% | −159.9% | −193.6% |
| FY22 | 59.7% | −218.8% | −380.8% |
| FY21 | 37.6% | - | −457.7% |
| FY20 | 34.3% | - | −780.6% |
| FY19 | 15% | - | −2157.7% |
| FY18 | - | - | - |
| FY17 | - | - | - |
| FY16 | - | - | - |
| FY15 | - | - | - |
- Biotricity
- Healthcare median
Show the numbers
| Year | Biotricity | Healthcare median |
|---|---|---|
| FY26 | −15% | −19.9% |
| FY25 | −61.1% | −40.6% |
| FY24 | −116.8% | −60.7% |
| FY23 | −193.6% | −97.1% |
| FY22 | −380.8% | −128.5% |
| FY21 | −457.7% | −129.2% |
| FY20 | −780.6% | −136.5% |
| FY19 | −2157.7% | −133.7% |
| FY18 | - | −173.4% |
| FY17 | - | −176.7% |
| FY16 | - | −164.8% |
| FY15 | - | −183.4% |
News
No stories filed under Biotricity yet - coverage appears here as the news feed clusters it.